Jl. Arbiser, GENETIC IMMUNODEFICIENCIES - CUTANEOUS MANIFESTATIONS AND RECENT PROGRESS, Journal of the American Academy of Dermatology, 33(1), 1995, pp. 82-89
In recent years, remarkable progress has been made in elucidating the
pathophysiology of genetic immunodeficiency disorders. Dermatologic ma
nifestations are prominent in these conditions; because of advances in
diagnosis and therapy, patients are living longer, increasing the lik
elihood that dermatologists will encounter patients with these disease
s. The genes of many of these disorders have been cloned, including ch
ronic granulomatous disease, X-linked immunodeficiencies, and myeloper
oxidase deficiency. Understanding the regulation and function of these
genes will not only affect patients with these rare disorders, but ma
y provide an insight into common dermatologic conditions, such as ecze
ma and cutaneous infection. Diagnosis, dermatologic manifestations, an
d therapy are discussed.